Clinical Trials Logo

Clinical Trial Summary

Esophageal capsule endoscopy is sedation-less alternative to upper endoscopy for evaluating esophageal lesions and potentially other upper gastrointestinal lesions. The purpose of this study was to determine whether esophageal capsule endoscopy is convenient and accurate as upper endoscopy for detection of esophageal varices and related lesions.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01079416
Study type Observational
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date June 2006
Completion date February 2008

See also
  Status Clinical Trial Phase
Recruiting NCT06017102 - Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices N/A
Recruiting NCT03624517 - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Phase 4
Recruiting NCT03989973 - Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
Completed NCT05485714 - Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
Completed NCT01851252 - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy Phase 1
Completed NCT01360515 - A Study of Disposable Transnasal Esophagoscope N/A
Recruiting NCT04602663 - Optimal Time for Follow up After Variceal Band Ligation N/A
Recruiting NCT04499898 - Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding Phase 2/Phase 3
Completed NCT00331188 - Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Phase 3
Enrolling by invitation NCT02767206 - Evaluation of Gastroesophageal Varices by Transnasal Endoscopy. N/A
Enrolling by invitation NCT05781828 - Noninvasive Methods For Prediction of Esophageal Varices in Children
Not yet recruiting NCT05199038 - Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study Phase 4
Recruiting NCT02740166 - Preventing Recurrent Bleeding After Eradication of Esophageal Varices Phase 4
Completed NCT01893541 - PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES? Phase 4
Terminated NCT00485290 - Effect of Meal on Portal and Esophagus Variceal Pressure N/A
Completed NCT01188733 - Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis Phase 1/Phase 2
Not yet recruiting NCT04254822 - HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients N/A
Recruiting NCT03212872 - Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding N/A
Completed NCT03748563 - Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis N/A
Completed NCT01059396 - Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal Phase 4